Therapy News and Research

RSS

Research reveals a possible strategy to prevent B-cell acute lymphoblastic leukemia

Short-term treatment with the drug ruxolitinib prevents B-cell acute lymphoblastic leukemia (B-ALL) in mice that have a genetic predisposition to the disease.

8 Feb 2022

Cognitive impairment in patients with long-COVID can be improved using brain stimulation

Many recovered COVID-19 patients continue to exhibit significant and long-lasting cognitive deficits in memory, attention, language comprehension and multitasking, as well as fatigue.

7 Feb 2022

New personalized test to detect leukemia relapse sooner and avoid false negative results

Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia (ALL), the most common cancer in children, to inform more effective treatment strategies and detect disease recurrence.

7 Feb 2022

Potential tumor vulnerability may be exploited to improve treatment of neuroblastoma

A Ludwig Cancer Research study has identified a potential vulnerability in neuroblastoma tumors that might be exploited to improve treatment of the aggressive childhood cancer, which accounts for roughly 15% of all deaths from pediatric malignancies.

7 Feb 2022

Two peanut allergy treatments for children found to be highly effective at inducing remission

Researchers have discovered two peanut allergy treatments for children that are both highly effective at inducing remission.

7 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

Study uses Promega LMR MSI Analysis System to detect microsatellite instability in multiple cancers

Researchers from Johns Hopkins University have shown that a new panel of long mononucleotide repeats might offer advantages over traditional microsatellite instability detection methods in certain types of solid tumors.

7 Feb 2022

Switching from metered-dose inhaler to a dry powder reduces carbon footprint of asthma treatment

Switching from a metered-dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition, finds a pharma industry sponsored study published online in the journal Thorax.

6 Feb 2022

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored by researchers from Harvard T.H. Chan School of Public Health.

4 Feb 2022

Researchers investigate how messenger substances signal inflammation during damaged cell removal

A research team from Cologne and Osnabrück has investigated in detail how messenger substances signal inflammation during the removal of damaged cells in the body.

4 Feb 2022

Gene therapy helps heart muscle cells electrically activate in live mice

Biomedical engineers at Duke University have demonstrated a gene therapy that helps heart muscle cells electrically activate in live mice.

4 Feb 2022

Researchers find a way to interfere with the energy pathway that promotes liver cancer spread

The World Health Organization projects that starting in 2030, over a million people will die each year from liver cancer.

4 Feb 2022

Drug used to treat skin and lung cancers slows the progression of ovarian cancer sub-type

A drug currently used to treat skin and lung cancers has been found to slow the progression of a form of ovarian cancer and increase the number of patients who respond to treatment, a clinical trial has found.

4 Feb 2022

The effect of SARS-CoV-2 infection on pregnant mothers, the placenta, and infants

A group of scientists focussed on assessing if SARS-CoV-2 infection causes any particular histologic change in the placenta.

4 Feb 2022

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

In a new study, researchers showed that 425 nm blue light can inactivate all major SARS CoV 2 variants.

4 Feb 2022

Gene therapy may be a curative treatment option for patients with transfusion-dependent beta-thalassemia

A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial published in The New England Journal of Medicine.

3 Feb 2022

Study identifies a genetic mutation linked to high risk of lethal childhood leukemia

A genetic variant changing just one base pair of nucleotides greatly increases risk of a high-risk subtype of childhood acute lymphoblastic leukemia (ALL), according to a Northwestern Medicine study published in Nature Genetics.

3 Feb 2022

CRISPRa method helps discover genes that play a role in immune cell biology

CRISPR genome editing has served as a powerful tool for deleting or altering DNA sequences and studying the resulting effect.

3 Feb 2022

Telehealth may be a supplement, not a replacement to in-person health-care visits

With the pandemic, there has been a rise in the use of virtual appointments for patients seeking health care. A new study by Tufts researchers, however, suggests that for many older and chronically ill patients, telehealth appointments may be most effective when they augment in-person health-care visits rather than fully replace them.

3 Feb 2022

Physical exercise increases synaptic resilience against age-related neuropathologies

Researchers from the UPV/EHU's Department of Pharmacology and the CIBER Mental Health network are taking part in a study published in the latest issue of the prestigious journal Alzheimer's & Dementia; it sheds light on the biological processes that mediate the beneficial effect of physical exercise on cognitive skills and mental health.

3 Feb 2022

Therapy News and Research

Research reveals a possible strategy to prevent B-cell acute lymphoblastic leukemia

Cognitive impairment in patients with long-COVID can be improved using brain stimulation

New personalized test to detect leukemia relapse sooner and avoid false negative results

Potential tumor vulnerability may be exploited to improve treatment of neuroblastoma

Two peanut allergy treatments for children found to be highly effective at inducing remission

Colchicine holds promise to reduce the risk of severe COVID-19

Study uses Promega LMR MSI Analysis System to detect microsatellite instability in multiple cancers

Switching from metered-dose inhaler to a dry powder reduces carbon footprint of asthma treatment

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

Researchers investigate how messenger substances signal inflammation during damaged cell removal

Gene therapy helps heart muscle cells electrically activate in live mice

Researchers find a way to interfere with the energy pathway that promotes liver cancer spread

Drug used to treat skin and lung cancers slows the progression of ovarian cancer sub-type

The effect of SARS-CoV-2 infection on pregnant mothers, the placenta, and infants

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

Gene therapy may be a curative treatment option for patients with transfusion-dependent beta-thalassemia

Study identifies a genetic mutation linked to high risk of lethal childhood leukemia

CRISPRa method helps discover genes that play a role in immune cell biology

Telehealth may be a supplement, not a replacement to in-person health-care visits

Physical exercise increases synaptic resilience against age-related neuropathologies

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News